V. Visco

发表

Difficult-to-control hypertension: identification of clinical predictors and use of ICT-based integrated care to facilitate blood pressure control

M. Illario, M. Ciccarelli, Guido Iaccarino, 2018, Journal of Human Hypertension.

Predictors of sacubitril/valsartan high dose tolerability in a real world population with HFrEF

F. Giallauria, M. Ciccarelli, G. Galasso, 2022, ESC heart failure.

A Novel Combination of High-Load Omega-3 Lysine Complex (AvailOm®) and Anthocyanins Exerts Beneficial Cardiovascular Effects

M. Ciccarelli, G. Galasso, C. Vecchione, 2022, Antioxidants.

Serum Uric Acid and Left Ventricular Mass in Essential Hypertension

M. Ciccarelli, Guido Iaccarino, C. Morisco, 2020, Frontiers in Cardiovascular Medicine.

A Multistep Approach to Deal With Advanced Heart Failure: A Case Report on the Positive Effect of Cardiac Contractility Modulation Therapy on Pulmonary Pressure Measured by CardioMEMS

A. Fiorentino, M. Ciccarelli, G. Galasso, 2022, Frontiers in Cardiovascular Medicine.

Artificial Intelligence as a Business Partner in Cardiovascular Precision Medicine: an Emerging Approach for Disease Detection and Treatment Optimization.

M. Ciccarelli, G. Galasso, C. Vecchione, 2020, Current medicinal chemistry.

Whole-Exome Sequencing Revealed New Candidate Genes for Human Dilated Cardiomyopathy

Domenico A. Palumbo, A. Weisz, M. Ciccarelli, 2022, Diagnostics.

Accuracy of home blood pressure measurement: the ACCURAPRESS study – a proposal of Young Investigator Group of the Italian Hypertension Society (Società Italiana dell’Ipertensione Arteriosa)

G. Grassi, M. Muiesan, Claudio Ferri, 2022, Blood pressure.

We are What We Eat: Impact of Food from Short Supply Chain on Metabolic Syndrome

M. Illario, M. Ciccarelli, Guido Iaccarino, 2019, Journal of clinical medicine.

Cardiovascular Implications of microRNAs in Coronavirus Disease 2019

M. Ciccarelli, M. Rusciano, C. Vecchione, 2022, The Journal of Pharmacology and Experimental Therapeutics.

The Role of Oxidative Stress in Cardiovascular Aging and Cardiovascular Diseases

M. Ciccarelli, G. Galasso, C. Vecchione, 2021, Life.

The Dark Side of Sphingolipids: Searching for Potential Cardiovascular Biomarkers

M. Ciccarelli, E. Sommella, M. Rusciano, 2023, Biomolecules.

Vitamin D, parathyroid hormone and cardiovascular risk: the good, the bad and the ugly

M. Illario, M. Ciccarelli, B. Trimarco, 2017, Journal of cardiovascular medicine.

It is easy to see, but it is better to foresee: a case report on the favourable alliance between CardioMEMS and levosimendan.

M. Ciccarelli, C. Vecchione, V. Visco, 2020, European heart journal. Case reports.

Post-COVID-19 Syndrome: Involvement and Interactions between Respiratory, Cardiovascular and Nervous Systems

G. Galasso, C. Vecchione, A. Carrizzo, 2022, Journal of clinical medicine.

Artificial Intelligence in Hypertension Management: An Ace up Your Sleeve

M. Ciccarelli, G. Galasso, M. Rusciano, 2023, Journal of cardiovascular development and disease.

Larger Blood Pressure Reduction by Fixed-Dose Compared to Free Dose Combination Therapy of ACE Inhibitor and Calcium Antagonist in Hypertensive Patients

M. Ciccarelli, Guido Iaccarino, Valeria Visco, 2017, Translational medicine @ UniSa.

The Metabolic Role of GRK2 in Insulin Resistance and Associated Conditions

D. Sorriento, M. Ciccarelli, M. Rusciano, 2021, Cells.

Artificial intelligence in cardiovascular prevention: new ways will open new doors

F. Giallauria, M. Ciccarelli, C. Vigorito, 2023, Journal of cardiovascular medicine.

Sacubitril/Valsartan vs. Standard Medical Therapy on Exercise Capacity in HFrEF Patients

M. Ciccarelli, C. Vecchione, C. Mancusi, 2023, Life.

Interventions to Address Cardiovascular Risk in Obese Patients: Many Hands Make Light Work

M. Ciccarelli, C. Vecchione, A. Carrizzo, 2023, Journal of cardiovascular development and disease.

Abstract P124: “Beyond Silos” Model of Homecare Improves Blood Pressure Control in Multimorbid Hypertensive Patients

M. Ciccarelli, Guido Iaccarino, G. Vairo, 2016 .

Acute heart failure: mechanisms and pre-clinical models-a Scientific Statement of the ESC Working Group on Myocardial Function.

A. Carrizzo, S. Zacchigna, C. Tocchetti, 2023, Cardiovascular research.

Larger Blood Pressure Reduction by Fixed-Dose Compared to Free Dose Combination Therapy of ACE Inhibitor and Calcium Antagonist in Hypertensive Patients

M. Ciccarelli, Guido Iaccarino, R. Finelli, 2017, Translational medicine @ UniSa.

Vitamin D: A Bridge between Kidney and Heart

A. Rispoli, N. Virtuoso, V. Visco, 2024, Life.

Prediabetes Increases the Risk of Frailty in Prefrail Older Adults With Hypertension: Beneficial Effects of Metformin

S. Jankauskas, A. Pansini, P. Mone, 2024, Hypertension.

Chronic Kidney Disease with Mineral Bone Disorder and Vascular Calcification: An Overview

C. Vecchione, A. Carrizzo, P. Di Pietro, 2024, Life.

Mechanisms of myocardial reverse remodelling and its clinical significance: A scientific statement of the ESC Working Group on Myocardial Function.

S. Zacchigna, C. Tocchetti, V. Visco, 2024, European journal of heart failure.

Frail hypertensive older adults with prediabetes and chronic kidney disease: insights on organ damage and cognitive performance - preliminary results from the CARYATID study

G. Santulli, A. Pansini, P. Mone, 2024, Cardiovascular diabetology.

An explainable model for predicting Worsening Heart Failure based on genetic programming.

A. Carrizzo, A. Rispoli, V. Visco, 2024, Computers in biology and medicine.

SGLT2 inhibitors and GLP-1 receptor agonists: which is the best anti-frailty drug?

P. Mone, V. Visco, Michele Ciccarelli, 2024, The lancet. Healthy longevity.